Related News
Ebola vaccines to be ready next year
Print Edition
THOUSANDS of experimental Ebola vaccine doses from Britain’s GlaxoSmithKline and the United States’ NewLink should be ready for use by early next year, the World Health Organization said yesterday.
“If everything goes well, we might be able to begin using the vaccines in some of the affected countries at the very start of next year,” said WHO Assistant Director-general Marie-Paule Kieny.
There is no licensed treatment or vaccine against the virus that has killed nearly 3,000 people in West Africa, and the UN health agency has endorsed rushing through experimental treatments and vaccines.
WHO is especially focusing on two experimental vaccines, one by GSK and the other by NewLink Genetics, and is working with both companies to accelerate clinical trials, Kieny said.
Some clinical trials have begun in the US and others are set to begin in Mali next week, she said.
The agency has said that if found to be safe some doses should be available to health workers by November.
The Canadian government has donated 800 viles of the NewLink vaccine to the WHO, and Kieny said thousands more will likely be available soon.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
